Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Total 13F shares
-
82,170,454
-
Share change
-
+2,163,578
-
Total reported value
-
$57,370,125,075
-
Put/Call ratio
-
167%
-
Price per share
-
$698.42
-
Number of holders
-
1,061
-
Value change
-
+$1,529,724,018
-
Number of buys
-
485
-
Number of sells
-
494
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q1 2022
As of 31 Mar 2022,
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) was held by
1,061 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,170,454 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, Capital World Investors, STATE STREET CORP, JPMORGAN CHASE & CO, WELLINGTON MANAGEMENT GROUP LLP, LOOMIS SAYLES & CO L P, Dodge & Cox, GEODE CAPITAL MANAGEMENT, LLC, and Capital International Investors.
This page lists
1,075
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.